Clinical Trial Update: [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin [NA]

View source ↗

Summary

This clinical trial assesses the use of the [18F]F-FAPI PET-CT tracer to identify carcinoma of unknown primary origin. It is currently recruiting at Erasmus Med…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary

Drugs mentioned

• [18F]F-FAPI PET/CT (18F-labeled fibroblast activation protein inhibitor (FAPI) PET tracer)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Cancer of Unknown Primary | NA | Status: RECRUITING